Summary
Wenqiang Chen is a translational neuroscientist and biology advisor with over 15 years of experience in in vivo physiology, cellular neurobiology, and preclinical modeling of neurodegenerative and metabolic diseases. Currently advising biology at Eli Lilly after a junior faculty appointment at Harvard Medical School and NIH- and Novo Nordisk-funded fellowships, he specializes in Alzheimer’s, aging, and metabolic dysfunction using rodent models, survival surgeries, and biomarker discovery to advance small molecule and biologic therapeutics. He has a strong track record developing and validating animal models for drug discovery and integrates molecular, biochemical, and cellular approaches to probe mechanism and therapeutic efficacy. Beyond bench science, he has led postdoc community initiatives and international fellowships, reflecting a commitment to scientific leadership and collaboration. An often-overlooked strength is his cross-disciplinary training from thalamic systems neuroscience to metabolic disease, which enables creative translational strategies bridging basic circuits and clinical targets.
9 years of coding experience
1 year of employment as a software developer
The University of Hong Kong (HKU)
English